MOLECULAR EXPRESS, INC has won 7 federal awards worth $3.8M in total across 1 agencies, with a median award of $3.6M. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.
| Title | Agency | Value | Date |
|---|---|---|---|
| DEVELOPMENT OF VESIVAX CO-ADJUVANT FORMULATION OF 2E151. | Department Of Health And Human Services | $600K | 2023-08-29 |
| THE CONTRACTOR SHALL TO ENGINEER NOVEL HIV GP41 ECTODOMAIN ANTIGENS (H | Department Of Health And Human Services | $300K | 2022-06-23 |
| THE CONTRACTOR SHALL TO EVALUATE THE DIFFERENT CO-DELIVERY METHODS OF | Department Of Health And Human Services | $300K | 2021-06-28 |
| THE OBJECTIVE OF THIS CONTRACT IS TO IDENTIFY A POTENTIAL HIV ANTIGEN- | Department Of Health And Human Services | $300K | 2020-05-27 |
| THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A VESIVAX PLATFORM-BASED | Department Of Health And Human Services | $300K | 2020-05-27 |
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.